HEM Pharma Decides to Acquire 57.58% Stake in Nice Health Device Corporation for Approximately 1.92 Billion Won, Aiming for Management Control and Synergy
HEM Pharma has decided to acquire a total of 380,000 shares including 100,000 common shares and 280,000 redeemable convertible preferred shares of Nice Health Device Corporation for approximately 1.92 billion won, securing a 57.58% stake and management control to pursue business synergy.
The target company, Nice Health Device Corporation, is a newly established entity in 2026 with no financial track record; its total assets stand at about 51.8 billion won but capital is only 3.3 billion won, indicating high leverage.
The acquisition cost is equivalent to only 0.53% of HEM Pharma's market capitalization of 363.76 billion won, resulting in no dilution for existing shareholders. However, the investment in a highly leveraged startup carries significant risk.
[AI Summary]HEM Pharma's small-scale acquisition of a controlling stake in a new company with opaque finances and high leverage may limit short-term stock price gains and warrants cautious investor monitoring.
KOSDAQ Filing Information
Decision on Acquisition of Stocks and Investment Securities of Other Corporations